weight loss semaglutide vs tirzepatide as Compared with for the Treatment of Obesity Tirzepatide vs. Semaglutide for Weight

S-LiTE was a randomized placebo-controlled trial with an initial weight loss phase before randomization

Clinical trials and post-marketing surveillance data consistently show that the following side effects occur commonly, though frequencies vary by product and dose: Nausea (affecting 15-50% of patients, depending on the specific product and dose) Vomiting and diarrhoea Constipation Abdominal pain or discomfort Reduced appetite These gastrointestinal symptoms typically diminish over time as the body adjusts to the medication, usually within 48 weeks

Modulates serotonin and dopamine systems in CNS and peripheral neural tissue

Mice were divided into 4 groups containing 8 animals each: sedentary control, sedentary supplemented with glutathione, exercise control, and exercise supplemented with glutathione